DULUTH, MN -- Following a recommendation from federal health regulators, Essentia Health is pausing the administration of the Johnson & Johnson COVID-19 vaccine.
Six reported cases of severe blood clotting in individuals in the U.S. who’d recently received the Johnson & Johnson vaccine are under review by the CDC and FDA.
Those cases, all of which were in women between 18-48 years old, have happened since April 12.
Over that same time period, more than 6.8 million doses of the Johnson & Johnson vaccine have been distributed nationwide.
Essentia will continue to administer the Pfizer/BioNTech and Moderna vaccines to anyone 16 and older in the communities they serve.
Health leaders assure the public that those who received the Pfizer/BioNTech and Moderna vaccines are different types of vaccines and have not exhibited this rare risk in the tens of millions of doses given.
Both patients and non-patients can schedule an appointment by using our online patient portal, MyChart, or by calling (833) 494-0836.
Click here for more information on Essentia’s vaccine program.